Evaluation of Filler Injection for Chin Profile Enhancement

Conditions

• Chin Asymmetry
• Chin Regression
• Jawline Contour Deficit

Eligibility Criteria

Sex

ALL

Age

22 Years - 55 Years

Healthy Volunteers

Accepted

Interventions

• HA Filler — DRUG
  Patients will receive FDA approved dosages of filler to the lower face region to treat chin regression or contour the chin, as per FDA approved indications. Patients are limited to the maximum recommended injected dose per patient for the initial and re-treatment (touch-up) injections of 4 mL. The injected volume per injection site should not exceed 2mL, the maximum volume studied and established by the manufacturer. Prior to injections, patients will be imaged with 3-dimensional photogrammetry and take a validated survey questionnaire (FACE-Q). Subjects will return post-injection in 2 weeks, 1 month, and 3 months for re-imaging and FACE-Q survey completion.

Study Details

The goal of this prospective study is to analyze volumetric changes in the lower face after hyaluronic acid filler injections over 90 days. The primary aim of the study is to quantify volume change of the lower face rea over time after injection of filler. The secondary aim is to collect patient related outcomes (PROs) via FACE-Q. Participants will receive hyaluronic acid filler injections (Restylane Lyft(for contouring of the chin. Each patient will receive FDA approved dosages of filler to the lower face region to treat chin regression or chin contouring, as per FDA approved indications. Prior to injections patients will be imaged with 3-dimensional photogrammetry. Subjects will return post-injection in 2 weeks, 1 month, and 3 moths for re-imaging.

Key Dates

First listed

Aug 20, 2026

Start date

Sep 30, 2026

Status verified

Aug 2026

Primary completion

Dec 1, 2026

Completion

Dec 1, 2026

Study Design

Enrollment

20 participants (estimated)

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Arms

• Experimental: Filler
  HA filler to chin region

Primary Outcome Measure

Volume change of the lower face area at 90 days post-intervention [ Time Frame: 90 days ]

Central Contacts

• Aamirah McCutchen
  215-360-0652
  [email protected]

Locations (1)

Find similar trials in Philadelphia, PA